To meet the demands of researchers and regulators, in vivo models are becoming more fit, while in vitro models, such as organ ...

A year after it was hit with a rejection from the FDA, Citius Pharmaceuticals has won over the U.S. regulator, scoring an ...

HEK cells were activated with interleukin-10 either alone (5 control samples, 4 ng per milliliter) or in the presence of control serum (10 samples) or serum from Patient 1 (3 samples) or Patient 2 ...

Lymphir, an immunotherapy, has been approved by the FDA to treat patients with relapsed or refractory cutaneous T-cell ...

"Multiple Th2-related inflammatory markers, like IL [interleukin]-5 and eotaxin-3, were reduced after dupilumab" in patients who responded to the therapy, said Manjunath, who co-presented the meeting ...

Response-guided maintenance treatment for psoriasis allowed patients with exceptional early responses to double the treatment ...

Tumor-infiltrating lymphocyte therapy in combination with high-dose interleukin-2 should be considered as a second-line ...

We report further data on the use of anti-IL-6 in the second and third trimesters of pregnancy for the management of COVID-19. When extrapolated, our data can inform shared decision making for ...

BurgerFi International, Sangamo Therapeutics, and Cel-Sci Corp. are the 3 Penny Stocks to watch on July 30, based on TipRanks ...

Following voluntary withdrawal in 2014, denileukin diftitox is now available again for the treatment of patients with ...

IND clearance achieved for MRT-6160, a VAV1-directed MGD in development for systemic and neurological autoimmune diseases; on track to initiate ...